Additional file 1 of Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

Additional file 1: Table S1. 133 proteins significantly changed (=/± 50%) between MS and Non-MS from CSF-PR. Quantified in minimum two studies, and changed in same direction in minimum two studies.

附加文件1：表S1。本表格收录了133个在脑脊液蛋白质组分析（CSF-PR）中，多发性硬化（MS）组与非多发性硬化（Non-MS）组间表达量变化幅度达±50%及以上的差异蛋白质。上述蛋白质至少在两项研究中完成定量检测，且至少在两项研究中呈现一致的变化方向。